Procyon Corporation (PCYN)
OTCMKTS
· Delayed Price · Currency is USD
0.201
0.00 (0.00%)
At close: Apr 23, 2026
Procyon Revenue
In the fiscal year ending June 30, 2024, Procyon had annual revenue of $4.98M with 6.35% growth. Procyon had revenue of $1.41M in the quarter ending June 30, 2024, with 17.51% growth.
Revenue
4.98M
Revenue Growth
+6.35%
P/S Ratio
0.33
Revenue / Employee
249.22K
Employees
20
Market Cap
1.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 4.98M | 297.77K | 6.35% |
| Jun 30, 2023 | 4.69M | -155.77K | -3.22% |
| Jun 30, 2022 | 4.84M | 122.76K | 2.60% |
| Jun 30, 2021 | 4.72M | 385.58K | 8.90% |
| Jun 30, 2020 | 4.33M | 142.90K | 3.41% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Panacea Life Sciences Holdings | 2.76M |
| Premier Biomedical | 14.28K |
| Anything Technologies Media | 257.70K |
| CBD Life Sciences | 178.45K |
| Nascent Pharma Holdings | 1.03M |
| CannaPharmaRX | 1.36M |
| Sibannac | 434.00 |
| Grapefruit USA | 34.85K |